On the other hand, triple-negative breast cancer (TNBC), defined as a lack of ERα, progesterone receptor (PR), or the overexpression of human epidermal growth factor receptor 2 (HER2/neu), constitutes 15% to 20% of breast cancers. The gene discussed is ERBB2; the disease is breast carcinoma.